Chemical Component Summary

NameLANOSTEROL
Identifiers(3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol
FormulaC30 H50 O
Molecular Weight426.72
TypeNON-POLYMER
Isomeric SMILESC[C@H](CCC=C(C)C)[C@H]1CC[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@@H]1CC3
InChIInChI=1S/C30H50O/c1-20(2)10-9-11-21(3)22-14-18-30(8)24-12-13-25-27(4,5)26(31)16-17-28(25,6)23(24)15-19-29(22,30)7/h10,21-22,25-26,31H,9,11-19H2,1-8H3/t21-,22-,25+,26+,28-,29-,30+/m1/s1
InChIKeyCAHGCLMLTWQZNJ-BQNIITSRSA-N

Chemical Details

Formal Charge0
Atom Count81
Chiral Atom Count7
Chiral AtomsC1, C10, C12, C13, C28, C3, C7
Bond Count84
Aromatic Bond Count0
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB03696 Different stereochemistry
NameLanosterol
Groupsexperimental
Categories
  • Cholestadienes
  • Cholestadienols
  • Cholestanes
  • Cholestenes
  • Hydrocarbons
CAS number79-63-0

Drug Targets

NameSequence SearchPharmacological ActionActions
Lanosterol synthaseMTEGTCLRRRGGPYKTEPATDLGRWRLNCERGRQTWTYLQDERAGREQTG...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682